We are live on ! Find out more
DOFI

DCVC Opportunity Fund II Portfolio holdings

AUM $13.9M
1-Year Est. Return 8.04%
This Fund
S&P 500
This Quarter Est. Return
-20.99%
1 Year Est. Return
+8.04%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$200M
AUM Growth
Cap. Flow
+$224M
Cap. Flow %
112.49%
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Industrials 46.26%
2 Healthcare 33.92%
3 Technology 19.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RKLB icon
1
Rocket Lab Corp
RKLB
$41.1B
$88.5M 44.33%
+7,203,035
New +$99M
RXRX icon
2
Recursion Pharmaceuticals
RXRX
$1.53B
$67.7M 33.92%
+3,951,141
New +$74.3M
S icon
3
SentinelOne
S
$6.67B
$39.6M 19.82%
+783,462
New +$45.9M
DM
4
DELISTED
Desktop Metal, Inc.
DM
$3.85M 1.93%
+77,717
New +$5.23M

Similar funds

DCVC Opportunity Fund II's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for DCVC Opportunity Fund II, which disclosed 4 positions worth $200M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Rocket Lab Corp: 7,203,035 shares worth $88.5M.

By sector, the portfolio is most concentrated in Industrials at 46% of assets, followed by Healthcare and Technology.

  • DCVC Opportunity Fund II's largest Q4 2021 buy was Rocket Lab Corp: 7,203,035 shares worth $88.5M.
  • DCVC Opportunity Fund II's ten largest holdings make up 100% of its $200M portfolio in Q4 2021.
  • DCVC Opportunity Fund II disclosed 4 positions in Q4 2021, its first 13F filing on record.

Based on DCVC Opportunity Fund II's 13F filing for Q4 2021, filed 14 Feb 2022.